Atria Wealth Solutions Inc. Has $1.76 Million Position in Mettler-Toledo International Inc. (NYSE:MTD)

Atria Wealth Solutions Inc. boosted its holdings in Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 4.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,589 shares of the medical instruments supplier’s stock after acquiring an additional 67 shares during the period. Atria Wealth Solutions Inc.’s holdings in Mettler-Toledo International were worth $1,761,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in MTD. Cambridge Investment Research Advisors Inc. raised its stake in Mettler-Toledo International by 8.0% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 176 shares of the medical instruments supplier’s stock valued at $242,000 after acquiring an additional 13 shares during the period. Raymond James Trust N.A. grew its holdings in Mettler-Toledo International by 19.7% in the 1st quarter. Raymond James Trust N.A. now owns 176 shares of the medical instruments supplier’s stock valued at $242,000 after buying an additional 29 shares in the last quarter. Vontobel Holding Ltd. grew its holdings in Mettler-Toledo International by 48.9% in the 1st quarter. Vontobel Holding Ltd. now owns 834 shares of the medical instruments supplier’s stock valued at $1,172,000 after buying an additional 274 shares in the last quarter. Sei Investments Co. grew its holdings in Mettler-Toledo International by 4.2% in the 1st quarter. Sei Investments Co. now owns 16,305 shares of the medical instruments supplier’s stock valued at $21,817,000 after buying an additional 662 shares in the last quarter. Finally, Prudential PLC acquired a new position in Mettler-Toledo International in the 1st quarter valued at $626,000. Institutional investors own 93.11% of the company’s stock.

Insider Buying and Selling at Mettler-Toledo International

In other news, Director Roland D. Diggelmann bought 315 shares of the company’s stock in a transaction on Monday, November 13th. The stock was purchased at an average cost of $1,026.54 per share, for a total transaction of $323,360.10. Following the completion of the transaction, the director now owns 405 shares of the company’s stock, valued at $415,748.70. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 2.40% of the company’s stock.

Mettler-Toledo International Stock Down 4.1 %

NYSE:MTD opened at $1,174.51 on Friday. The stock’s 50-day simple moving average is $1,183.41 and its 200 day simple moving average is $1,143.38. The firm has a market capitalization of $25.46 billion, a PE ratio of 32.73, a price-to-earnings-growth ratio of 4.98 and a beta of 1.15. Mettler-Toledo International Inc. has a twelve month low of $928.49 and a twelve month high of $1,615.97.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its earnings results on Thursday, February 8th. The medical instruments supplier reported $9.40 EPS for the quarter, missing the consensus estimate of $10.32 by ($0.92). The firm had revenue of $934.90 million during the quarter, compared to the consensus estimate of $959.45 million. Mettler-Toledo International had a net margin of 20.82% and a negative return on equity of 1,140.73%. Mettler-Toledo International’s revenue for the quarter was down 11.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $12.10 earnings per share. On average, analysts anticipate that Mettler-Toledo International Inc. will post 39.78 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. StockNews.com raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Friday. Citigroup reaffirmed a “sell” rating and issued a $975.00 price objective (down from $1,050.00) on shares of Mettler-Toledo International in a report on Monday, December 11th. JPMorgan Chase & Co. reduced their target price on Mettler-Toledo International from $1,300.00 to $1,100.00 and set a “neutral” rating on the stock in a report on Tuesday, October 17th. Wells Fargo & Company reduced their target price on Mettler-Toledo International from $1,520.00 to $1,300.00 and set an “overweight” rating on the stock in a report on Monday, November 13th. Finally, The Goldman Sachs Group reduced their target price on Mettler-Toledo International from $1,185.00 to $1,030.00 and set a “neutral” rating on the stock in a report on Monday, November 13th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $1,223.71.

Read Our Latest Analysis on Mettler-Toledo International

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the United States and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Further Reading

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.